glp-1 and type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness In type 1 patients with
Description
Early detection through regular screening is critical to preventing colon cancer and improving outcomes

doi: 10.1111/acel.12446

The development also reinforces a key competitive distinction in the GLP-1 marketplace

But theyre not the only ones because Eli Lilly will never be outdone by Novo Nordisk
